influenza
viru
iv
highli
contagi
singlestrand
rna
viru
infect
upper
lower
respiratori
tract
human
host
innat
immun
tolllik
receptor
shown
previous
cell
myeloid
origin
recogn
viral
replic
intermedi
doublestrand
rna
dsrna
thu
dsrna
critic
outcom
infect
appear
activ
compon
viral
infect
stimul
antivir
activ
accumul
replic
mani
virus
includ
influenza
viru
promin
sourc
dsrna
includ
viral
rna
contain
doublestrand
secondari
structur
dsrna
form
viral
replic
furthermor
contribut
directli
immun
respons
respiratori
epitheli
cell
influenza
viru
dsrna
therefor
dsrna
treatment
alway
use
mimic
viral
infect
cell
line
macrophag
dsrna
viral
infect
stimul
express
proinflammatori
cytokin
tumor
necrosi
factor
cyclooxygenas
cox
ratelimit
enzym
biosynthet
pathway
prostaglandin
thromboxan
prostaglandin
play
import
role
mani
biolog
process
alter
prostanoid
product
associ
varieti
ill
includ
acut
chronic
inflamm
cardiovascular
diseas
colon
cancer
two
isoform
cox
describ
constitut
express
almost
tissu
induc
form
enzym
express
respons
inflammatori
stimuli
growth
factor
involv
mediat
pain
inflammatori
process
previou
studi
identifi
two
viral
protein
nucleoprotein
spike
protein
sarscov
involv
upregul
prostaglandin
synthes
varieti
cell
synthes
arachidon
acid
enzym
prostaglandin
synthetas
level
measur
access
activ
describ
refer
previous
call
natur
killer
cell
transcript
recogn
proinflammatori
cytokin
recent
mainli
express
natur
killer
cell
cell
epitheli
cell
blood
monocyt
induc
proinflammatori
cytokin
murin
periton
macrophag
well
phorbol
esterdifferenti
human
cell
play
import
role
innat
adapt
immun
respons
synerg
wellcharacter
player
innat
immun
recent
document
furthermor
contribut
synov
rheumatoid
arthriti
stimul
mycobacterium
tuberculosi
synerg
ligand
stimul
releas
manner
recent
proteinas
identifi
specif
bind
protein
cleav
cytokin
enhanc
activ
number
investig
demonstr
viral
infect
stimul
express
follow
accumul
howev
role
influenza
viru
infect
regul
newli
describ
proinflammatori
factor
express
still
unclear
furthermor
sinc
obligatori
mediat
inflamm
question
aris
whether
interact
two
protein
act
independ
effector
host
inflammatori
respons
viral
infect
gene
express
associ
inflammatori
process
aim
studi
investig
role
influenza
viru
infect
regul
express
determin
molecular
mechan
respons
result
show
influenza
viru
infect
poli
ic
treatment
activ
express
heretofor
unrecogn
mechan
influenza
viru
stimul
express
feedback
inhibit
express
studi
examin
consecut
adult
influenza
viru
infect
male
femal
age
yr
seroposit
influenza
antigen
healthi
adult
male
femal
age
yr
seroneg
influenza
antigen
adult
seroneg
marker
hepat
b
viru
hbv
hepat
c
viru
hcv
hepat
delta
viru
hiv
investig
serum
sampl
obtain
help
hubei
provinci
center
diseas
control
prevent
hubei
cdc
inform
consent
obtain
patient
collect
blood
sampl
research
approv
institut
review
board
colleg
life
scienc
wuhan
univers
accord
guidelin
protect
human
subject
influenza
viru
strain
use
studi
provid
china
center
type
cultur
collect
cctcc
stock
viru
propag
embryon
chicken
egg
h
allanto
fluid
harvest
aliquot
store
use
final
concentr
viru
infect
use
studi
multipl
infect
moi
gift
dr
kenneth
k
wu
univers
texashouston
medic
school
houston
texa
usa
luciferas
report
vector
contain
promot
region
construct
previous
promot
amplifi
human
genom
dna
pcr
use
follow
primer
sens
gttaagcttagggaaagtccagactcggg
antisens
insert
vector
gener
promot
luciferas
gene
fusion
plasmid
construct
creat
rtpcr
amplif
open
read
frame
human
lung
epitheli
cell
creat
vector
beta
gene
amplifi
use
follow
primer
catgaattccatgtgcttcccgaagg
sens
ctactcgaggtatcttcattttgaggattg
antisens
ecori
xhoi
site
introduc
respect
pcr
product
clone
ecori
xhoi
site
stratagen
gener
plasmid
beta
protein
tag
flag
ten
gene
influenza
viru
obtain
rtpcr
infect
cell
construct
vector
gener
ivgen
express
plasmid
use
specif
pair
primer
influenza
viru
gene
follow
ha
acgggatccgatggagaaaatagtgctt
sens
acgctcgagtgaactcacaaattta
antisens
na
sens
aaagggcccctacttgtcaatggtgaatgg
antisens
np
aaaggatcccatggcgtctcaaggcacc
sens
accgaattcttaattgtcatactcc
antisens
acaggatccgatggattccaacactgtgtc
sens
cttgaattctcagccaccttatttc
antisens
acaggatccgatggattccaacactgtgtc
sens
ctagggcccatcattaaataagctgaaacga
antisens
tctgaattcgatgagtcttctaac
sens
ttagggcccgcaacaacaagaggatcact
antisens
tctgaattcgatgagtcttctaac
sens
tttctcgagggtagttttttactccaat
antisens
pa
aatggatcctatggaagactttgtgcgac
sens
caggggccctacttcagtgcatgtgcgag
antisens
caaacggatcccatggatgtcaatccgac
sens
caagaagctttcactatttctgccgtctg
antisens
gcaaaagcaggtcaaatata
sens
gtttttaaacaattcgacacta
antisens
sirna
plasmid
construct
ligat
correspond
pair
oligonucleotid
neo
ambion
inc
augstin
tx
usa
base
sequenc
describ
previous
construct
confirm
dna
sequenc
monoclon
mous
antibodi
human
purchas
cayman
chemic
compani
ann
arbor
mi
usa
polyclon
goat
antibodi
human
purchas
r
system
inc
usa
polyclon
goat
antibodi
specif
human
purchas
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
n
methanesulphonamid
promega
madison
wi
dissolv
dmso
use
indic
concentr
accord
refer
aspirin
sigma
st
loui
mo
usa
synthet
polyinosinicpolycytidyl
acid
poli
ic
sigma
st
loui
mo
usa
recombin
human
peprotech
london
uk
dissolv
pb
use
final
concentr
mm
uml
respect
hek
cell
cultur
dmem
gibcobrl
usa
human
lung
epitheli
cell
cultur
media
gibcobrl
usa
respect
media
supplement
fetal
calf
serum
uml
penicillin
streptomycin
sulfat
cell
cultur
maintain
incub
cell
plate
densiti
cell
per
plate
plate
grown
confluenc
reach
time
transfect
plasmid
express
plasmid
prltk
promega
cotransfect
cell
use
lipofectamin
reagent
invitrogen
necessari
poli
ic
aspirin
ad
cultur
media
transfect
h
posttransfect
cell
serumstarv
anoth
h
harvest
luciferas
activ
measur
h
transfect
accord
manufactur
instruct
promega
renilla
luciferas
activ
determin
intern
control
transfect
effici
previous
describ
assay
perform
triplic
express
rel
vector
mock
control
rlu
luciferas
activ
luc
total
rna
isol
cell
use
trizol
reagent
invitrogen
carlsbad
ca
usa
treat
dnase
reversetranscrib
mlv
revers
transcriptas
promega
random
primer
takara
pcr
perform
reaction
detect
primer
pair
describ
follow
sens
antisens
ctactcgaggtatcttcattttgaggattg
detect
primer
describ
previous
amplifi
pcr
normal
reaction
primer
design
detect
known
isoform
human
pcr
product
analyz
electrophoresi
agaros
gel
contain
ethidium
bromid
protein
extract
cultur
cell
prepar
suspend
cell
lysi
buffer
edta
triton
proteinas
inhibitor
cocktail
sonic
centrifug
concentr
protein
supernat
quantifi
use
protein
assay
kit
biorad
western
blot
analysi
perform
use
antibodi
sampl
load
normal
use
antibodi
immunoblot
visual
ecl
detect
system
pierc
rockford
il
usa
increas
metabolit
enzym
catalysi
epitheli
cell
level
cultur
medium
assay
biotrak
prostaglandin
enzym
immunoassay
system
r
system
accord
manufactur
protocol
elisa
assay
develop
use
antibodi
polypeptid
hkeeltpqkcsepqsskoh
gl
biochem
ltd
shanghai
china
synthes
antigen
make
protein
standard
curv
elisa
prepar
coat
bottom
plate
dilut
serum
sampl
cultur
media
captur
antibodi
incub
one
hour
wash
three
time
tbst
follow
hrplabel
secondari
antibodi
incub
minut
final
wash
six
time
tbst
elisa
develop
tmb
sigma
substrat
absorb
doublewavelength
nm
measur
concentr
calcul
standard
curv
experi
reproduc
carri
triplic
quadrupl
set
experi
repeat
least
three
time
similar
result
repres
one
shown
result
present
student
test
pair
sampl
use
determin
statist
signific
differ
consid
statist
signific
valu
serum
level
significantli
higher
cohort
patient
influenza
viru
infect
investig
comparison
healthi
control
individu
vs
pgml
vs
pgml
respect
p
mann
whitneyu
describ
tabl
report
influenza
viru
activ
express
cell
cultur
system
dsrna
induc
product
follow
releas
initi
investig
whether
influenza
viru
infect
dsrna
play
role
regul
express
cell
infect
influenza
viru
treat
poli
ic
result
show
cell
suscept
influenza
viru
infect
appar
cytopath
effect
observ
viral
infect
cultur
supernat
cell
lysat
harvest
differ
time
point
infect
induct
follow
h
h
h
h
h
accumul
fig
product
fig
cultur
supernat
measur
describ
materi
method
section
mrna
fig
protein
fig
express
level
lysat
cell
examin
semiquantit
rtpcr
western
blot
analys
respect
result
suggest
influenza
viru
infect
dsrna
treatment
could
activ
express
cell
timedepend
manner
identifi
viral
compon
play
import
role
ivstimul
proinflammatori
factor
express
screen
ten
protein
influenza
viru
ha
na
np
pa
poli
ic
mimic
viral
replic
intermedi
dsrna
luciferas
assay
result
show
poli
ic
poli
ic
import
factor
induct
either
fig
fig
promot
activ
mean
dsrna
key
viral
compon
involv
ivtrigg
express
viral
infect
studi
focus
function
dsrna
inflammatori
respons
iv
infect
defin
role
regul
influenza
viru
induc
proinflammatori
factor
poli
ic
treatment
use
mimic
influenza
viru
infect
follow
experi
report
previous
first
effect
activ
promot
determin
cell
cotransfect
report
plasmid
plu
differ
concentr
mention
fig
use
empti
vector
control
result
luciferas
activ
assay
show
level
promot
activ
increas
overexpress
block
inhibitor
dosedepend
manner
secondli
determin
effect
activ
mrna
level
protein
express
cell
transfect
differ
amount
result
rtpcr
use
primer
show
level
mrna
increas
amount
increas
level
mrna
remain
rel
constant
fig
furthermor
product
cultur
supernat
stimul
overexpress
dosedepend
manner
fig
thirdli
result
rtpcr
analys
show
level
mrna
activ
poli
ic
suppress
inhibitor
dose
depend
manner
fig
furthermor
accumul
cultur
supernat
stimul
poli
ic
suppress
fig
taken
togeth
data
suggest
upstream
regulatori
factor
dsrnatrigg
product
effect
regul
promot
determin
cell
cotransfect
report
plasmid
result
luciferas
activ
assay
show
level
promot
activ
decreas
overexpress
fig
determin
effect
regul
mrna
express
product
cell
transfect
differ
amount
treat
poli
ic
induc
result
rtpcr
use
primer
show
level
mrna
decreas
amount
increas
level
mrna
remain
rel
constant
fig
furthermor
product
cultur
supernat
suppress
overexpress
dosedepend
manner
fig
confirm
result
sirna
cotransfect
along
report
plasmid
cell
treat
poli
ic
result
luciferas
activ
assay
show
level
promot
activ
increas
knock
fig
furthermor
product
cultur
supernat
stimul
poli
ic
enhanc
knock
fig
taken
togeth
data
suggest
play
import
role
inflammatori
respons
follow
influenza
depend
posit
regulatori
order
neg
feedback
biosynthesi
also
first
observ
confirm
regulatori
loop
cell
infect
influenza
viru
treat
without
select
inhibitor
nonselect
cox
inhibitor
aspirin
wide
use
antiinflammatori
drug
result
show
ivtrigg
releas
fig
fig
product
cultur
supernat
inhibit
either
aspirin
indic
import
proinflammatori
factor
downstream
influenza
viru
infect
effect
regul
iv
infect
induc
product
also
determin
found
releas
cell
cultur
supernat
stimul
iv
infect
increas
fig
product
decreas
fig
knock
taken
togeth
data
demonstr
novel
inflammatori
pathway
respons
influenza
viru
infect
dsrna
treatment
identifi
describ
fig
result
demonstr
signific
increas
serum
level
observ
influenza
infect
patient
compar
healthi
individu
viral
infect
result
increas
synthesi
increas
product
influenza
viru
infect
poli
ic
treatment
human
lung
epitheli
cell
abl
induc
mrna
protein
express
well
accumul
cell
cultur
supernat
induc
influenza
viru
infect
mechan
although
proinflammatori
factor
identifi
obligatori
mediat
airway
inflamm
influenza
viru
infect
virtual
littl
current
known
regard
regul
newli
identifi
proinfammatori
factor
influenza
viru
infect
mechan
wherebi
influenza
viru
upregul
express
present
studi
provid
consider
new
inform
relev
issu
identifi
first
regulatori
loop
upregul
express
feedback
inhibit
express
influenza
viru
infect
lung
epitheli
cell
present
possibl
crosstalk
two
import
proinflammatori
factor
nitric
oxid
synthas
no
cox
extens
examin
differ
cell
line
tissu
differ
pathophysiolog
condit
conflict
result
relationship
evalu
compar
iv
infect
induc
level
cell
cultur
human
individu
signific
differ
observ
increas
cell
cultur
versu
human
individu
like
proinflammatori
factor
abl
increas
sharpli
physiolog
condit
due
complex
inflamm
network
proinflammatori
factor
regul
two
viral
compon
viral
replic
intermedi
dsrna
identifi
involv
iv
infect
trigger
express
cell
contribut
directli
inflammatori
respons
respiratori
epitheli
cell
influenza
viru
dsrna
focus
function
dsrna
regul
express
studi
role
viral
protein
proinflammatori
process
need
investig
cyclooxygenas
metabol
arachidon
acid
prostaglandin
pg
thromboxan
elucid
crucial
inflammatori
respons
tumorigenesi
nonsteroid
antiinflammatori
drug
nsaid
select
inhibit
use
clinic
treat
inflammatori
arthropathi
alway
caus
mani
side
effect
gastrointestin
gi
mucosa
damag
cardiovascular
advers
event
aspirin
one
classic
nsaid
antiinflammatori
activ
associ
cyclooxygenas
inhibit
directli
indirectli
nsaidassoci
gi
mucos
injuri
import
clinic
problem
increas
knowledg
physiolog
role
enzym
varieti
tissu
includ
stomach
kidney
togeth
withdraw
clinic
trial
rofecoxib
valdecoxib
cardiovascular
toxic
challeng
benefit
select
inhibit
studi
identifi
novel
downstream
proinflammatori
factor
could
potenti
target
screen
antiinflammatori
drug
less
advers
effect
summari
studi
provid
new
insight
novel
model
describ
fig
influenza
viru
poli
ic
trigger
proinflammatori
factor
express
product
subsequ
host
inflammatori
respons
model
demonstr
locat
upstream
posit
regulatori
pathway
crosstalk
two
gene
describ
follow
upregul
product
convers
attenu
activ
